In last trading session, Boston Scientific Corp. (NYSE:BSX) saw 6.32 million shares changing hands with its beta currently measuring 0.80. Company’s recent per share price level of $88.07 trading at $1.65 or 1.91% at ring of the bell on the day assigns it a market valuation of $129.69B. That closing price of BSX’s stock is at a discount of -0.02% from its 52-week high price of $88.09 and is indicating a premium of 44.19% from its 52-week low price of $49.15. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 5.35 million shares which gives us an average trading volume of 5.56 million if we extend that period to 3-months.
For Boston Scientific Corp. (BSX), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.51. Splitting up the data highlights that, out of 15 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 1 suggested the stock as a Hold whereas 13 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0.59 in the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Boston Scientific Corp. (NYSE:BSX) trade information
Upright in the green during last session for gaining 1.91%, in the last five days BSX remained trading in the green while hitting it’s week-highest on Friday, 10/18/24 when the stock touched $88.07 price level, adding 0.72% to its value on the day. Boston Scientific Corp.’s shares saw a change of 52.34% in year-to-date performance and have moved 1.11% in past 5-day. Boston Scientific Corp. (NYSE:BSX) showed a performance of 5.21% in past 30-days. Number of shares sold short was 10.92 million shares which calculate 2.07 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 78 to the stock, which implies a fall of -12.91% to its current value. Analysts have been projecting 48 as a low price target for the stock while placing it at a high target of 118. It follows that stock’s current price would jump 45.5% in reaching the projected high whereas dropping to the targeted low would mean a gain of 45.5% for stock’s current value.
Boston Scientific Corp. (BSX) estimates and forecasts
Statistics highlight that Boston Scientific Corp. is scoring comparatively higher than the scores of other players of the relevant industry. The company added 30.80% of value to its shares in past 6 months, showing an annual growth rate of 17.07% while that of industry is 11.60. Apart from that, the company came raising its revenue forecast for fiscal year 2024. This year revenue growth is estimated to rise 14.40% from the last financial year’s standing.
24 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 4.04B for the same. And 24 analysts are in estimates of company making revenue of 4.28B in the next quarter. Company posted 3.53B and 3.73B of sales in current and next quarters respectively a year earlier.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -2.05% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 17.49% while estimates for its earnings growth in next 5 years are of 13.00%.
Boston Scientific Corp. (NYSE:BSX)’s Major holders
Insiders are in possession of 0.18% of company’s total shares while institution are holding 92.57 percent of that, with stock having share float percentage of 92.74%. Investors also watch the number of corporate investors in a company very closely, which is 92.57% institutions for Boston Scientific Corp. that are currently holding shares of the company. FMR LLC is the top institutional holder at BSX for having 141.46 million shares of worth $10.89 billion. And as of 2024-06-30, it was holding 9.6337 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 129.87 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.8444 of outstanding shares, having a total worth of $10.0 billion.
